See more : Primavera Capital Acquisition Corporation (PV) Income Statement Analysis – Financial Results
Complete financial analysis of Cardlytics, Inc. (CDLX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cardlytics, Inc., a leading company in the Advertising Agencies industry within the Communication Services sector.
You may be interested
- Healthlead Public Company Limited (HL.BK) Income Statement Analysis – Financial Results
- Mining Global Inc. (MNGG) Income Statement Analysis – Financial Results
- Hövding Sverige AB (publ) (HOVD.ST) Income Statement Analysis – Financial Results
- Henan Yuneng Holdings Co.,Ltd. (001896.SZ) Income Statement Analysis – Financial Results
- Chongqing Qin’an M&E PLC. (603758.SS) Income Statement Analysis – Financial Results
Cardlytics, Inc. (CDLX)
About Cardlytics, Inc.
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 309.20M | 298.54M | 267.12M | 186.89M | 210.43M | 150.68M | 130.37M | 112.82M | 77.63M |
| Cost of Revenue | 178.83M | 185.91M | 163.78M | 123.62M | 130.97M | 96.00M | 80.26M | 72.41M | 52.49M |
| Gross Profit | 130.38M | 112.63M | 103.34M | 63.27M | 79.46M | 54.68M | 50.11M | 40.41M | 25.14M |
| Gross Profit Ratio | 42.17% | 37.73% | 38.69% | 33.86% | 37.76% | 36.29% | 38.44% | 35.82% | 32.38% |
| Research & Development | 51.35M | 54.44M | 38.10M | 17.53M | 11.70M | 16.21M | 12.15M | 13.90M | 11.60M |
| General & Administrative | 58.81M | 81.45M | 66.22M | 46.53M | 36.72M | 34.23M | 20.10M | 21.36M | 18.20M |
| Selling & Marketing | 57.43M | 74.75M | 66.00M | 45.31M | 43.83M | 41.88M | 31.93M | 31.26M | 32.78M |
| SG&A | 116.24M | 156.19M | 132.22M | 91.84M | 80.55M | 76.11M | 52.03M | 52.62M | 50.98M |
| Other Expenses | 98.46M | 37.54M | 29.87M | 7.83M | 4.54M | -2.10M | 6.28M | -13.26M | -432.00K |
| Operating Expenses | 266.05M | 248.17M | 200.19M | 117.20M | 96.78M | 95.60M | 67.21M | 70.74M | 64.78M |
| Cost & Expenses | 444.87M | 434.08M | 363.97M | 240.82M | 227.76M | 191.60M | 147.46M | 143.15M | 117.27M |
| Interest Income | 3.85M | 1.44M | 297.00K | 440.00K | 829.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 6.18M | 2.56M | 12.56M | 3.05M | 1.38M | 3.26M | 8.24M | 0.00 | 0.00 |
| Depreciation & Amortization | 29.52M | 43.74M | 33.66M | 12.42M | 7.40M | 3.28M | 3.03M | 4.22M | 2.19M |
| EBITDA | -99.00M | -418.98M | -89.91M | -39.51M | -12.79M | -45.97M | -8.37M | -24.00M | -37.45M |
| EBITDA Ratio | -32.02% | -30.75% | -22.91% | -22.65% | -6.08% | -20.49% | -10.35% | -0.15% | -49.41% |
| Operating Income | -135.67M | -135.54M | -96.85M | -53.92M | -17.33M | -40.92M | -17.10M | -56.23M | -39.64M |
| Operating Income Ratio | -43.88% | -45.40% | -36.26% | -28.85% | -8.23% | -27.15% | -13.12% | -49.84% | -51.06% |
| Total Other Income/Expenses | 968.00K | -8.93M | -13.83M | -1.50M | 181.00K | -12.13M | -2.54M | -19.46M | -1.00M |
| Income Before Tax | -134.70M | -466.71M | -136.43M | -55.42M | -17.14M | -53.04M | -19.64M | -75.70M | -40.64M |
| Income Before Tax Ratio | -43.56% | -156.33% | -51.07% | -29.65% | -8.15% | -35.20% | -15.07% | -67.09% | -52.35% |
| Income Tax Expense | 0.00 | -1.45M | -7.86M | 3.05M | 548.00K | -12.13M | 5.74M | 32.11M | -16.00K |
| Net Income | -134.70M | -465.26M | -128.57M | -58.47M | -17.69M | -53.04M | -19.64M | -75.70M | -40.63M |
| Net Income Ratio | -43.56% | -155.85% | -48.13% | -31.29% | -8.41% | -35.20% | -15.07% | -67.09% | -52.33% |
| EPS | -3.69 | -13.92 | -3.99 | -2.15 | -0.75 | -2.78 | -1.01 | -5.40 | -2.90 |
| EPS Diluted | -3.69 | -13.92 | -3.99 | -2.15 | -0.75 | -2.78 | -1.01 | -5.40 | -2.90 |
| Weighted Avg Shares Out | 36.49M | 33.42M | 32.20M | 27.21M | 23.75M | 19.06M | 19.52M | 14.03M | 14.03M |
| Weighted Avg Shares Out (Dil) | 36.49M | 33.42M | 32.20M | 27.21M | 23.75M | 19.06M | 19.52M | 14.03M | 14.03M |
Cardlytics, Inc. (CDLX) Q3 2024 Earnings Call Transcript
Cardlytics, Inc. (CDLX) Q3 2024 Earnings Call Transcript
Cardlytics (CDLX) Reports Q3 Loss, Tops Revenue Estimates
Cardlytics (CDLX) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to earnings of $0.01 per share a year ago.
Cardlytics Announces Third Quarter 2024 Financial Results
ATLANTA, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the third quarter ended September 30, 2024.
Cardlytics Announces Timing of Its Third Quarter 2024 Earnings Release
ATLANTA, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that its financial results for the third quarter ending September 30, 2024 will be released on November 6, 2024, after...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
NEW YORK, NY / ACCESSWIRE / September 29, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman
SAN FRANCISCO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Cardlytics, Inc. (NASDAQ: CDLX) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
NEW YORK , Sept. 25, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX).
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
NEW YORK, NY / ACCESSWIRE / September 23, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
NEW YORK, NY / ACCESSWIRE / September 21, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Source: https://incomestatements.info
Category: Stock Reports